Navigation Links
Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
Date:3/26/2008

Upgrade to boost capacity by up to 23 percent for moisture-barrier film

PHILADELPHIA, March 26 /PRNewswire/ -- Honeywell (NYSE: HON) announced today that it will expand production of Aclar(R) film to meet growing demand for the clear, moisture-barrier material, which is used extensively in pharmaceutical packaging.

An upgrade of existing production capability, combined with overall productivity improvements, is expected to boost Aclar production by up to 23 percent by end of 2008 at the business' Pottsville, Pa. facility.

"This is another step in our continued strategy to invest to meet the packaging needs of the pharmaceutical industry now and in the future," said Jeff Czarnecki, global segment leader for the specialty films segment of Honeywell Performance Products. Czarnecki noted that the business implemented productivity improvements at the Pottsville site in 2007 which also boosted capacity.

Rick Knight, global business manager for healthcare, said pharmaceutical companies worldwide continue to demand thermoformed packaging material with superior barrier capabilities. "Honeywell is committed to supporting pharmaceutical companies globally as they introduce new products to the marketplace," Knight said.

The announcement was made at INTERPHEX(TM), the world's largest and most comprehensive pharmaceutical conference and exhibition. The event focuses on leading-edge technology, education, and sourcing of products and services that drive scientific innovation for life sciences manufacturing.

As part of its commitment to the pharmaceutical industry, Honeywell is continuing its technical training and educational series to address critical aspects of thermoform packaging. The program consists of half- and one-day workshops.

Aclar is a polychlorotrifluoroethylene (PCTFE) fluoropolymer film that has excellent moisture barrier and chemical stability. Aclar film is crystal clear, biochemically inert, chemical-resistant, nonflammable, and plasticizer- and stabilizer-free.

In addition to Aclar, Honeywell Specialty Films manufactures Capran(R) biaxially oriented nylon film, also known as biaxially oriented polyamide (BOPA) film; Capran(R) heat stabilized nylon film; Aclon(TM) fluoropolymer resins, which provide the highest moisture barrier of any clear thermoplastic resins; and Honeywell PCTFE, ECTFE and PMP barrier films for high performance industrial applications.

Honeywell Specialty Materials, based in Morristown, N.J., is a $4.9 billion, global leader in providing customers with high-performance specialty materials, including fluorine products; specialty films and additives; advanced fibers and composites; intermediates; specialty chemicals; electronic materials and chemicals; and technologies and materials for petroleum refining.

Honeywell International is a $36 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit http://www.honeywell.com.

This report contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Honeywell
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Murad Expands International Presence With Appointment of Danny Guez
2. Sigma-Aldrich Amends Credit Facility and Expands Commercial Paper Program
3. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
4. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
5. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
6. Life Spine Expands Home Office Space, More Than Doubling Space Occupied
7. Millennium Expands IBD Franchise with Addition of New Development Candidate
8. inVentiv Clinical Expands Operations to Emerging Latin American Region
9. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
10. AlphaDetail, Inc. Expands Management Team
11. ANSYS Expands HPC Benchmarking Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , ... May 03, 2016 , ... Elizabeth Murray has ... parrots to join her with one on her shoulder and one on her arm. ... parking lot because of years of mitral valve prolapse. , The valves of the ...
(Date:5/3/2016)... ... ... Excessive panting in the car or cowering when new guests arrive are ... only manifests itself as trembling or ‘tail between the legs,’ but a pet ... about it,” says Dr. Jim Lowe, technical services veterinarian for Tomlyn pet health products ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... been selected by Tidelands Health, a three hospital system in South Carolina, to ... on the lookout for technology that enhances communication, drives workflow efficiencies and improves ...
(Date:5/3/2016)... ... 2016 , ... Boston Children’s Hospital today announced its new pediatric Simulation (SIM) ... or rare procedures in an environment that looks and feels real. , Located in ... inventors and “hackers” to develop and test new devices or software platforms and see ...
(Date:5/3/2016)... OH (PRWEB) , ... May 03, 2016 , ... Each ... a leading cause of death across the United States and account for one death ... and mental impairments or are permanently disabled. HCR ManorCare is launching a video series ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Click here for supplemental information regarding ... the nation,s largest independent specialty pharmacy, announced today ... acquire Valley Campus Pharmacy, Inc., doing business as ... pharmacy that provides individualized patient care, based in ... 2015, TNH generated approximately $400 million in revenue. ...
(Date:4/28/2016)... BURLINGAME, Calif. , April 28, 2016 /PRNewswire/ ... first-ever widely accessible breast and ovarian cancer risk ... cancer panel analyzing 30 genes that highly impact ... and women. Available today, the Color Test analyzes ... pancreatic, prostate, stomach, and uterine cancers. The Color ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
Breaking Medicine Technology: